NGMD — NuGen Medical Devices Balance Sheet
0.000.00%
Last trade - 00:00- CA$13.62m
- CA$23.25m
- CA$1.01m
Annual balance sheet for NuGen Medical Devices, fiscal year end - December 31st, CAD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|
| Period Length: | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final |
| Cash | ||||
| Cash and Equivalents | ||||
| Cash and Short Term Investments | 1.75 | 0.131 | 0.464 | 6.95 |
| Net Total Accounts Receivable | ||||
| Net Total Receivables | 0.311 | 0.243 | 0.355 | 0.33 |
| Total Inventory | ||||
| Prepaid Expenses | ||||
| Total Other Current Assets | ||||
| Total Current Assets | 2.15 | 0.567 | 1.33 | 7.8 |
| Gross Property, Plant And Equipment | ||||
| Accumulated Depreciation | ||||
| Net Property, Plant And Equipment | 0.018 | 0.163 | 0.031 | 0.009 |
| Net Goodwill | ||||
| Net Intangible Assets | ||||
| Total Assets | 8.84 | 6.85 | 6.95 | 12.9 |
| Accounts Payable | ||||
| Notes Payable / Short Term Debt | ||||
| Current Portion of Long Term Debt / Capital Leases | ||||
| Total Other Current Liabilities | ||||
| Total Current Liabilities | 1.23 | 1.73 | 3.29 | 1.34 |
| Long Term Debt | ||||
| Capital Lease Obligations | ||||
| Total Long Term Debt | ||||
| Total Debt | ||||
| Total Other Liabilities | ||||
| Total Liabilities | 7.19 | 9.11 | 9.01 | 18.6 |
| Common Stock | ||||
| Retained Earnings (Accumulated Deficit) | ||||
| Other Equity | ||||
| Total Equity | 1.66 | -2.26 | -2.06 | -5.67 |
| Total Liabilities & Shareholders' Equity | 8.84 | 6.85 | 6.95 | 12.9 |
| Total Common Shares Outstanding |